Source: Contraception. Unidade: FSP
Subjects: DISPOSITIVOS ANTICONCEPCIONAIS, PESOS E MEDIDAS CORPORAIS (EFEITOS DE DROGAS), COMPOSIÇÃO CORPORAL (EFEITOS DE DROGAS), ESTEROIDES, HORMÔNIOS (FARMACOLOGIA), FÁRMACOS (FISIOLOGIA), MÉTODO DE IMPEDÂNCIA
ABNT
MELO, Nilson Roberto de et al. A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet® (gestodene75/EE20) on body fat. Contraception, v. 70, n. 1, p. 65-71, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2003.10.016. Acesso em: 06 nov. 2024.APA
Melo, N. R. de, Aldrighi, J. M., Faggion, D., Faggion Jr., D., Reyes, V. R. O. Y., Souza, J. B., et al. (2004). A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet® (gestodene75/EE20) on body fat. Contraception, 70( 1), 65-71. doi:10.1016/j.contraception.2003.10.016NLM
Melo NR de, Aldrighi JM, Faggion D, Faggion Jr. D, Reyes VROY, Souza JB, Fernandes CE, Larson E. A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet® (gestodene75/EE20) on body fat [Internet]. Contraception. 2004 ; 70( 1): 65-71.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.contraception.2003.10.016Vancouver
Melo NR de, Aldrighi JM, Faggion D, Faggion Jr. D, Reyes VROY, Souza JB, Fernandes CE, Larson E. A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet® (gestodene75/EE20) on body fat [Internet]. Contraception. 2004 ; 70( 1): 65-71.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.contraception.2003.10.016